Latest Cancer treatments Stories
Trial led by St. Jude Children's Research Hospital investigators succeeds in keeping cure rates high for young patients with favorable-risk Hodgkin lymphoma while reducing their chances of serious treatment side effects A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at risk for second cancers, infertility, heart and other problems later. St....
ATLANTA, June 27, 2012 /PRNewswire/ -- Elekta swept the top three rankings in the KLAS research firm's recently released 2012 Best in KLAS Awards: Medical Equipment & Infrastructure report*. Elekta's Leksell Gamma Knife® Perfexion(TM) radiosurgery system and Elekta Synergy® and Elekta Infinity(TM) radiation therapy systems earned the #1, #2 and #3 rankings, respectively, out of eight possible rankings. In the report, Perfexion scored 93.9 out of 100, and 100 percent of...
SUNNYVALE, Calif., June 27, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that doctors at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center in San Francisco, Calif. are now treating cancer patients with the TomoTherapy® System, the only radiation therapy system specifically designed for integrated, daily, 3D image-guided, intensity modulated radiation...
MADISON, Wis., June 27, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry S. Palmin, President and CEO of Novelos, will present a corporate update at the LHA Life Sciences & Medical Technologies Virtual Conference on Thursday, June 28, 2012. Mr. Palmin is scheduled to present at 12:30 p.m. Eastern time. A webcast of the Novelos presentation may be...
Trial led by St. Jude Children's Research Hospital investigators succeeds in keeping cure rates high for young patients with favorable-risk Hodgkin lymphoma while reducing their chances of serious treatment side effects MEMPHIS, Tenn., June 26, 2012 /PRNewswire-USNewswire/ -- A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at risk for...
BANNOCKBURN, Ill., June 26, 2012 /PRNewswire/ -- Pinnacle Biologics, Inc., a bio-pharmaceutical technology company developing and manufacturing novel therapies for oncology and rare diseases and European-based INTERmedic, a medical laser and light technology company, announced a global manufacturing and distribution agreement of INTERmedic's latest photodynamic therapy (PDT) laser for exclusive use with Pinnacle's PHOTOFRIN ® (porfimer sodium) for injection. PDT is a two-step...
Death of first wife makes things more personal for scientist working to improve quality of life of brain tumor patients receiving radiation therapy WINSTON-SALEM, N.C., June 26, 2012 /PRNewswire-USNewswire/ -- The following is being released by Wake Forest Baptist Medical Center HealthWire: (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO) Mike Robbins knows all too well the likely outcome when patients are diagnosed with brain tumors that are "high grade." The median...
SUNNYVALE, Calif., June 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master research and collaboration agreement with Erasmus Medical Center (MC), a leading research center in Rotterdam, the Netherlands and the largest of the eight university medical centers in the country. Accuray and Erasmus MC will partner on cutting-edge research in radiation oncology with the goal of advancing...
AHMEDABAD, India, June 26, 2012 /PRNewswire/ -- HCG Cancer Centre, the first hospital in India to introduce clinical treatments using an advanced TrueBeam(TM) treatment system from Varian Medical Systems (NYSE: VAR), has conducted a workshop focusing on stereotactic body radiotherapy (SBRT) for treating cancers of the lung, liver, spine, and prostate. More than 150 specialists from across India attended the medical meeting in Ahmedabad. "This meeting enabled our fellow oncologists...
PALO ALTO, Calif., June 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that it will report results for the third quarter of fiscal year 2012 following the close of regular trading on Wednesday, July 25, 2012. The news release will be followed by a teleconference available to all interested parties at 2:00 p.m. PT. The news release and a link to the conference call webcast will be available on the company website at: www.varian.com/investor. To access...
